NM_001008503.2(OPRM1):c.118A>G (p.Asn40Asp) | 4988 | OPRM1 | drug response | 1799971 | RCV000010146; RCV000211310; RCV000211400; RCV000211220; RCV000211345; RCV000211165; RCV000211208; RCV000211332; RCV000211154; RCV000211247; RCV000211368; | N | Gene:100188802,MedGen:C1864733,OMIM:610064; MedGen:CN236463; MedGen:CN236521; MedGen:CN236567; MedGen:CN236590; MedGen:CN236592; MedGen:CN236596; MedGen:CN236601; MedGen:CN236602; MedGen:CN236604; MedGen:CN236606 | 6 | 154360797 | 154360797 | NM_001008503.2:c.118A>G | NP_001008503.2:p.Asn40Asp | NC_000006.11:g.154360797A>G | OMIM Allelic Variant:600018.0001,PharmGKB Clinical Annotation:655385241,PharmGKB Clinical Annotation:981204641,PharmGKB Clinical Annotation:982034197,Pha | CN236463 alfentanil response - Metabolism/PK; CN236521 Drugs used in opioid dependence response - Metabolism/PK; CN236590 ethanol response - Toxicity/ADR; CN236592 fentanyl response - Metabolism/PK; CN236596 heroin response - Metabolism/PK; CN236601 | | |